Acquired Epidermodysplasia Verruciformis Secondary to Hodgkin Lymphoma
DOI:
https://doi.org/10.24950/rspmi/Imagem/293/18/2/2019Keywords:
Cellular Immunity, Epidermodysplasia Verruciformis, Hodgkin Disease, Papillomavirus InfectionsDownloads
References
Rogers H, Macgregor J, Nord K, Tyring S, Rady P, Engler D, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2009; 60:315-20. doi: 10.1016/j.jaad.2008.08.035.
Zampetti A, Giurdanella F, Manco S, Linder D, Gnarra M, Guerriero G, Feliciani C. Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment. Dermatol Surg. 2013. 39:974-80. doi: 10.1111/dsu.12135.
Majewski S, Jablonska S. Why epidermodysplasia verruciformis - a rare genetic disease - has raised such great interest. Int J Dermatol. 2004; 43:309-11.
Slivnick DJ, Ellis TM, Nawrocki JF, Fisher RI. The impact of Hodgkin’s disease on the immune system. Semin Oncol. 1990; 17:673-82.
Kumar R, Penny R. Cell-mediated immune deficiency in Hodgkin’s disease. Elsevier Biomedical Press. 1982; 3:269-73.
Romagnani S, Maggi E, Biagiotti R, Giudizi MG, Amadori A, Ricci M. Altered proportions of Tp and Ty cell subpopulations in patients with Hodgkin’s disease. Scand J Immunol. 1978; 7:511-4.
Downloads
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna